Retrospective study of Pneumocystis pneumonia over half a century in mainland China
Wang et al.
J Med Microbiol 2011;60:631-638.
ABSTRACT
| FULL TEXT
Update on the diagnosis and treatment of Pneumocystis pneumonia
Carmona and Limper
Ther Adv Respir Dis 2011;5:41-59.
ABSTRACT
Racial and Sex Disparities in Life Expectancy Losses among HIV-Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral Therapy
Losina et al.
Clinical Infectious Diseases 2009;49:1570-1578.
ABSTRACT
| FULL TEXT
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
Peleg et al.
Clinical Infectious Diseases 2007;44:1307-1314.
ABSTRACT
| FULL TEXT
The Survival Benefits of AIDS Treatment in the United States
Walensky et al.
The Journal of Infectious Disease 2006;194:11-19.
ABSTRACT
| FULL TEXT
Screening for HIV: Recommendation Statement
U.S. Preventive Services Task Force*
ANN INTERN MED 2005;143:32-37.
ABSTRACT
| FULL TEXT
Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2005;143:55-73.
ABSTRACT
| FULL TEXT
Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
Rodriguez and Fishman
Clin. Microbiol. Rev. 2004;17:770-782.
ABSTRACT
| FULL TEXT
Trimethoprim-Sulfamethoxazole Revisited
Masters et al.
Arch Intern Med 2003;163:402-410.
ABSTRACT
| FULL TEXT
Prevention of Human Immunodeficiency Virus--Related Opportunistic Infections in France: A Cost-Effectiveness Analysis
Yazdanpanah et al.
Clinical Infectious Diseases 2003;36:86-96.
ABSTRACT
| FULL TEXT
Antiparasitic Agent Atovaquone
Baggish and Hill
Antimicrob. Agents Chemother. 2002;46:1163-1173.
FULL TEXT
Prophylaxis for Human Immunodeficiency Virus-Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines
Goldie et al.
Arch Intern Med 2002;162:921-928.
ABSTRACT
| FULL TEXT
Discontinuation of Pneumocystis carinii Prophylaxis in Patients Infected with Human Immunodeficiency Virus: A Meta-Analysis and Decision Analysis
Trikalinos and Ioannidis
Clinical Infectious Diseases 2001;33:1901-1909.
ABSTRACT
| FULL TEXT
New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia
Kovacs et al.
JAMA 2001;286:2450-2460.
ABSTRACT
| FULL TEXT
Prevention of Infection Caused by Pneumocystis carinii in Transplant Recipients
Snydman and Fishman
Clinical Infectious Diseases 2001;33:1397-1405.
ABSTRACT
| FULL TEXT
Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia
Hendrick
J. Clin. Pathol. 2001;54:412-413.
FULL TEXT
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
KASISKE et al.
J. Am. Soc. Nephrol. 2000;11:S1-S86.
ABSTRACT
| FULL TEXT
Risk Factors for Community-Acquired Pneumonia among Persons Infected with Human Immunodeficiency Virus
Navin et al.
The Journal of Infectious Disease 2000;181:158-164.
ABSTRACT
| FULL TEXT
Comparison of High and Low Doses of Trimethoprim-Sulfamethoxazole for Primary Prevention of Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients
Ribera et al.
Clinical Infectious Diseases 1999;29:1461-1466.
ABSTRACT
| FULL TEXT
Emergence of Trimethoprim-Sulfamethoxazole Resistance in the AIDS Era
Martin et al.
The Journal of Infectious Disease 1999;180:1809-1818.
ABSTRACT
| FULL TEXT
State of the Evidence: Current Status and Prospects of Meta-Analysisin Infectious Diseases
Ioannidis and Lau
Clinical Infectious Diseases 1999;29:1178-1185.
ABSTRACT
| FULL TEXT
Prevention of Infection Due to Pneumocystis carinii
Fishman
Antimicrob. Agents Chemother. 1998;42:995-1004.
FULL TEXT
The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections
Freedberg et al.
JAMA 1998;279:130-136.
ABSTRACT
| FULL TEXT